GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,995 | -2,246 | -5,006 | 471 | -4,940 |
| Depreciation Amortization | 472 | 734 | 803 | 851 | 467 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -12 |
| Accounts receivable | N/A | N/A | 145 | 14 | 133 |
| Accounts payable and accrued liabilities | N/A | N/A | 252 | -49 | 64 |
| Other Working Capital | 78 | 380 | 561 | 157 | 811 |
| Other Operating Activity | 910 | 195 | 3,076 | -2,105 | 2,806 |
| Operating Cash Flow | $-1,535 | $-937 | $-169 | $-661 | $-671 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -64 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -3,060 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 3,060 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -93 | -44 |
| Other Investing Activity | 0 | 0 | 0 | -93 | -44 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-93 | $-108 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 3,666 |
| Debt Issued | N/A | 2,233 | N/A | N/A | N/A |
| Debt Repayment | N/A | -25 | N/A | N/A | 1,350 |
| Common Stock Issued | 46 | N/A | N/A | 500 | 70 |
| Other Financing Activity | 250 | 0 | 0 | 0 | -3,713 |
| Financing Cash Flow | $296 | $2,208 | $N/A | $500 | $1,373 |
| Beginning Cash Position | 1,293 | 22 | 191 | 445 | 614 |
| End Cash Position | 54 | 1,293 | 22 | 191 | 1,208 |
| Net Cash Flow | $-1,239 | $1,271 | $-169 | $-254 | $594 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,535 | -937 | -169 | -661 | -671 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -64 |
| Free Cash Flow | -1,535 | -937 | -169 | -661 | -735 |